Synonyms:Radotinib, 926037-48-1, supect, IY-5511, Radotinib(IY-5511), IY5511, UNII-I284LJY110, 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyrazin-2-ylpyrimidin-2-yl)amino]benzamide, I284LJY110, 926037-48-1 (free base), 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyrazin-2-yl)pyrimidin-2-yl]amino}benzamide, IY5511HCl, Radotinib [INN], 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyrazin-2-yl)pyrimidin-2-yl)amino)benzamide, Radotinib (IY-5511), Radotinib; IY-5511;, GTPL7814, SCHEMBL3359952, CHEMBL4297524, DTXSID90239069, AOB87198, BCP12554, EX-A1035, MFCD27956910, NSC800989, s8134, ZINC59749972, AKOS026750428, AKOS032950010, CCG-269914, DB12323, NSC-800989, SB11083, NCGC00390586-01, NCGC00481590-01, 4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-trifluoromethylphenyl)-3-(4-(pyrazin-2-yl)pyrimidin-2-ylamino)benzamide, AC-30633, AS-55884, DA-40474, KB-146009, B5846, FT-0700508, A13029, 2?,3?,17?-Trihydroxy-7?-6-oxo-5?-androstan, J-690392, Q15269680
Pubchem:PUBCHEM:16063245
Id:8727b86b-9deb-5c02-b9e9-0d0b4cc297be
Description:nan
